We are live on ! Find out more
Bank of Nova Scotia

Bank of Nova Scotia Portfolio holdings

AUM $66.2B
1-Year Est. Return 46.3%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+46.3%
3 Year Est. Return
+126.16%
5 Year Est. Return
+142.96%
10 Year Est. Return
+457.74%
AUM
$38.6B
AUM Growth
+$7.19B
Cap. Flow
+$1.49B
Cap. Flow %
3.87%
Top 10 Hldgs %
33.21%
Holding
1,306
New
163
Increased
426
Reduced
462
Closed
146

Sector Composition

Rank Sector Weight
1 Financials 26.98%
2 Energy 12.77%
3 Technology 9.62%
4 Communication Services 7.12%
5 Industrials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
201
Applied Materials
AMAT
$435B
$24.4M 0.06%
251,074
-256,217
-51% -$24.6M
CDW icon
202
CDW
CDW
$17.1B
$24.2M 0.06%
135,584
+79,439
+141% +$14M
ZTS icon
203
Zoetis
ZTS
$30.4B
$24M 0.06%
163,636
+9,524
+6% +$1.41M
PH icon
204
Parker-Hannifin
PH
$135B
$23.9M 0.06%
82,173
+24,638
+43% +$7.05M
VRSN icon
205
VeriSign
VRSN
$25.6B
$23.4M 0.06%
113,978
+106,128
+1,352% +$20.3M
AZO icon
206
AutoZone
AZO
$49.7B
$23.2M 0.06%
9,417
+2,724
+41% +$6.58M
CTVA icon
207
Corteva
CTVA
$50.4B
$23M 0.06%
391,504
+328,023
+517% +$20.8M
PXD
208
DELISTED
Pioneer Natural Resource Co.
PXD
$22.8M 0.06%
99,897
+36,276
+57% +$8.83M
EWW icon
209
iShares MSCI Mexico ETF
EWW
$1.9B
$22.6M 0.06%
457,240
-28,460
-6% -$1.43M
CRM icon
210
Salesforce
CRM
$158B
$22.6M 0.06%
170,117
-196,758
-54% -$28.7M
BMRN icon
211
BioMarin Pharmaceuticals
BMRN
$13.6B
$22.4M 0.06%
216,049
+211,797
+4,981% +$19.9M
CTSH icon
212
Cognizant
CTSH
$26.2B
$22.3M 0.06%
389,229
+333,846
+603% +$19.6M
LW icon
213
Lamb Weston
LW
$7.3B
$22.1M 0.06%
247,124
+139,557
+130% +$11.9M
EBAY icon
214
eBay
EBAY
$45.5B
$22.1M 0.06%
532,215
+476,810
+861% +$19.7M
KEY icon
215
KeyCorp
KEY
$24.5B
$21.9M 0.06%
1,258,619
+1,176,542
+1,433% +$20.7M
TXN icon
216
Texas Instruments
TXN
$253B
$21.9M 0.06%
132,361
+51,680
+64% +$8.62M
FRC
217
DELISTED
First Republic Bank
FRC
$21.4M 0.06%
175,373
+166,868
+1,962% +$20.4M
LMT icon
218
Lockheed Martin
LMT
$140B
$21.1M 0.05%
43,394
-5,648
-12% -$2.62M
APD icon
219
Air Products & Chemicals
APD
$67.7B
$21.1M 0.05%
68,391
+48,912
+251% +$13.8M
MET icon
220
MetLife
MET
$61.4B
$20.9M 0.05%
288,774
-79,493
-22% -$5.69M
MSI icon
221
Motorola Solutions
MSI
$77.7B
$20.6M 0.05%
80,114
+54,042
+207% +$13.5M
AZTD icon
222
Aztlan Global Stock Selection DM SMID ETF
AZTD
$38.5M
$20.6M 0.05%
+1,040,130
New +$20.4M
AXP icon
223
American Express
AXP
$232B
$20.4M 0.05%
138,190
+94,133
+214% +$13.9M
ED icon
224
Consolidated Edison
ED
$39.9B
$20.2M 0.05%
212,277
+179,193
+542% +$16.3M
SYK icon
225
Stryker
SYK
$133B
$20.2M 0.05%
82,677
+54,781
+196% +$12.4M

Similar funds

Bank of Nova Scotia's Q4 2022 Portfolio in Review

As of Q4 2022, Bank of Nova Scotia held 1,306 positions worth $38.6B, up 23% from $31.5B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bank of Nova Scotia deployed $1.49B of net new capital in Q4 2022, opening 163 new positions and adding to 426 existing holdings. Its largest new stake was Brookfield Asset Management: 4,740,541 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 29% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Enbridge, an estimated $185M trimmed.

  • Bank of Nova Scotia's largest Q4 2022 buy was Brookfield Asset Management: 4,740,541 shares worth $136M.
  • Bank of Nova Scotia added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $1.87B increase.
  • Bank of Nova Scotia's biggest Q4 2022 reduction was Enbridge, cutting an estimated $185M.
  • Bank of Nova Scotia fully exited Atlassian in Q4 2022, selling an estimated $99.4M.
  • Bank of Nova Scotia's ten largest holdings make up 33% of its $38.6B portfolio in Q4 2022.
  • Bank of Nova Scotia opened 163 new positions and closed 146 in Q4 2022.
  • Bank of Nova Scotia's portfolio value rose 23% quarter-over-quarter to $38.6B.

Based on Bank of Nova Scotia's 13F filing for Q4 2022, filed 9 Feb 2023.